Shell Asset Management Co
- SEC CIK
- 0001211028
- Latest filing
- Nov 7, 2025
VERV holding history
Verve Therapeutics, Inc. in every 13F filed by Shell Asset Management Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VERV overviewAll 13F holders of VERVFull Q3 2025 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −5,806−100.0% | Sold out | Holders |
| Q2 2025 | 5,806 | $65.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 5,806 | $27.0K | <0.1% | −229−3.8% | Reduced | Holders |
| Q4 2024 | 6,035 | $34.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 6,035 | $29.0K | <0.1% | – | No prior filing | Holders |
| Q2 2024 | – | – | – | – | Not filed | Holders |
| Q1 2024 | 5,769 | $28.0K | <0.1% | −647−10.1% | Reduced | Holders |
| Q4 2023 | 6,416 | $89.0K | <0.1% | +6,416 | New | Holders |